NEW YORK (dpa-AFX Broker) - The US investment bank Goldman Sachs has lowered its price target for Carl Zeiss Meditec from 90 to 67 euros and left its rating at "Sell". This was analyst Richard Felton's reaction to the medical technology group's massive forecast cut on Monday evening. His lowered estimates now reflect weaker trends in all business areas./ag/zb

Publication of the original study: 17.06.2024 / 22:05 / BST

First-time dissemination of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------